These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32804306)

  • 1. Quantification of [
    van de Stadt EA; Yaqub M; Lammertsma AA; Poot AJ; Schober PR; Schuit RC; Smit EF; Bahce I; Hendrikse NH
    EJNMMI Res; 2020 Aug; 10(1):97. PubMed ID: 32804306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic analysis of [18F]FAZA in non-small cell lung cancer patients.
    Verwer EE; van Velden FH; Bahce I; Yaqub M; Schuit RC; Windhorst AD; Raijmakers P; Lammertsma AA; Smit EF; Boellaard R
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1523-31. PubMed ID: 23740374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of erlotinib therapy on [(11)C]erlotinib uptake in EGFR mutated, advanced NSCLC.
    Bahce I; Yaqub M; Errami H; Schuit RC; Schober P; Thunnissen E; Windhorst AD; Lammertsma AA; Smit EF; Hendrikse NH
    EJNMMI Res; 2016 Dec; 6(1):10. PubMed ID: 26857779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of simplified methods to measure 18F-FLT uptake changes in EGFR-mutated non-small cell lung cancer patients undergoing EGFR tyrosine kinase inhibitor treatment.
    Frings V; Yaqub M; Hoyng LL; Golla SS; Windhorst AD; Schuit RC; Lammertsma AA; Hoekstra OS; Smit EF; Boellaard R;
    J Nucl Med; 2014 Sep; 55(9):1417-23. PubMed ID: 24970910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Simplified Methods for Quantification of
    Kramer GM; Yaqub M; Vargas HA; Schuit RC; Windhorst AD; van den Eertwegh AJM; van der Veldt AAM; Bergman AM; Burnazi EM; Lewis JS; Chua S; Staton KD; Beattie BJ; Humm JL; Davis ID; Weickhardt AJ; Scott AM; Morris MJ; Hoekstra OS; Lammertsma AA
    J Nucl Med; 2019 Sep; 60(9):1221-1227. PubMed ID: 30850488
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantification of 18F-fluorocholine kinetics in patients with prostate cancer.
    Verwer EE; Oprea-Lager DE; van den Eertwegh AJ; van Moorselaar RJ; Windhorst AD; Schwarte LA; Hendrikse NH; Schuit RC; Hoekstra OS; Lammertsma AA; Boellaard R
    J Nucl Med; 2015 Mar; 56(3):365-71. PubMed ID: 25678491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between Biodistribution and Tracer Kinetics of
    van de Stadt EA; Yaqub M; Schuit RC; Bartelink IH; Leeuwerik AF; Schwarte LA; de Langen AJ; Hendrikse H; Bahce I
    Diagnostics (Basel); 2022 Apr; 12(4):. PubMed ID: 35453931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simplified Methods for Quantification of
    Jansen BHE; Yaqub M; Voortman J; Cysouw MCF; Windhorst AD; Schuit RC; Kramer GM; van den Eertwegh AJM; Schwarte LA; Hendrikse NH; Vis AN; van Moorselaar RJA; Hoekstra OS; Boellaard R; Oprea-Lager DE
    J Nucl Med; 2019 Dec; 60(12):1730-1735. PubMed ID: 31000583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole tumor kinetics analysis of
    McGowan DR; Skwarski M; Papiez BW; Macpherson RE; Gleeson FV; Schnabel JA; Higgins GS; Fenwick JD
    EJNMMI Res; 2018 Aug; 8(1):73. PubMed ID: 30069753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic modeling of a novel hypoxia PET tracer [
    Verwer EE; Zegers CM; van Elmpt W; Wierts R; Windhorst AD; Mottaghy FM; Lambin P; Boellaard R
    EJNMMI Phys; 2016 Dec; 3(1):30. PubMed ID: 27957730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of PD-L1 Expression with
    Huisman MC; Niemeijer AN; Windhorst AD; Schuit RC; Leung D; Hayes W; Poot A; Bahce I; Radonic T; Oprea-Lager DE; Hoekstra OS; Thunnissen E; Hendrikse NH; Smit EF; de Langen AJ; Boellaard R
    J Nucl Med; 2020 Oct; 61(10):1455-1460. PubMed ID: 32060213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of [
    Iqbal R; Kramer GM; Frings V; Smit EF; Hoekstra OS; Boellaard R;
    EJNMMI Res; 2018 Mar; 8(1):22. PubMed ID: 29594931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of [18F]afatinib as new TKI-PET tracer for EGFR positive tumors.
    Slobbe P; Windhorst AD; Stigter-van Walsum M; Schuit RC; Smit EF; Niessen HG; Solca F; Stehle G; van Dongen GA; Poot AJ
    Nucl Med Biol; 2014 Oct; 41(9):749-57. PubMed ID: 25066021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3'-deoxy-3'-18F-fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non-small cell lung cancer.
    Zannetti A; Iommelli F; Speranza A; Salvatore M; Del Vecchio S
    J Nucl Med; 2012 Mar; 53(3):443-50. PubMed ID: 22331221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict PET Image Quality of Three Generations EGFR TKI in Advanced-Stage NSCLC Patients.
    Bartelink IH; van de Stadt EA; Leeuwerik AF; Thijssen VLJL; Hupsel JRI; van den Nieuwendijk JF; Bahce I; Yaqub M; Hendrikse NH
    Pharmaceuticals (Basel); 2022 Jun; 15(7):. PubMed ID: 35890095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative PET imaging study with the reversible and irreversible EGFR tyrosine kinase inhibitors [(11)C]erlotinib and [(18)F]afatinib in lung cancer-bearing mice.
    Slobbe P; Windhorst AD; Stigter-van Walsum M; Smit EF; Niessen HG; Solca F; Stehle G; van Dongen GA; Poot AJ
    EJNMMI Res; 2015; 5():14. PubMed ID: 25853020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative parametric perfusion images using 15O-labeled water and a clinical PET/CT scanner: test-retest variability in lung cancer.
    van der Veldt AA; Hendrikse NH; Harms HJ; Comans EF; Postmus PE; Smit EF; Lammertsma AA; Lubberink M
    J Nucl Med; 2010 Nov; 51(11):1684-90. PubMed ID: 20956480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative and Simplified Analysis of 11C-Erlotinib Studies.
    Yaqub M; Bahce I; Voorhoeve C; Schuit RC; Windhorst AD; Hoekstra OS; Boellaard R; Hendrikse NH; Smit EF; Lammertsma AA
    J Nucl Med; 2016 Jun; 57(6):861-6. PubMed ID: 26848174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of Tau Load Using [
    Golla SSV; Timmers T; Ossenkoppele R; Groot C; Verfaillie S; Scheltens P; van der Flier WM; Schwarte L; Mintun MA; Devous M; Schuit RC; Windhorst AD; Lammertsma AA; Boellaard R; van Berckel BNM; Yaqub M
    Mol Imaging Biol; 2017 Dec; 19(6):963-971. PubMed ID: 28374171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parametric Method Performance for Dynamic 3'-Deoxy-3'-
    Kramer GM; Frings V; Heijtel D; Smit EF; Hoekstra OS; Boellaard R;
    J Nucl Med; 2017 Jun; 58(6):920-925. PubMed ID: 28572289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.